mir-320a suppresses colorectal cancer progression by targeting Rac1

Carcinogenesis

Volumn 35, Issue 4, 2014, Pages 886-895

  Zhao, Hongchao ^a   Dong, Taotao ^b   Zhou, Houmin ^c   Wang, Linlin ^d   Huang, Ao ^a   Feng, Bo ^a   Quan, Yingjun ^a   Jin, Runsen ^a   Zhang, Wenpeng ^a   Sun, Jing ^a   Zhang, Daohai ^e   Zheng, Minhua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

^c QINGDAO MUNICIPAL HOSPITAL   (China)

^d JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 320A; RAC1 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN TARGETING;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA PRIMERS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RAC1 GTP-BINDING PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84898663928     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt378     Document Type: Article

References (53)

1. Parkin, D.M. et al. (2005) Global cancer statistics, 2002. Cancer J. Clin., 55, 74-108.
2. Hanahan, D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.
3. Ferlay, J. et al. (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol., 18, 581-592.
4. Nadal, C. et al. (2007) Is there a genetic signature for liver metastasis in colorectal cancer? World J. Gastroenterol., 13, 5832-5844.
5. Janakiram, N.B. et al. (2008) Molecular markers and targets for colorectal cancer prevention. Acta Pharmacol. Sin., 29, 1-20.
6. Farazi, T.A. et al. (2011) miRNAs in human cancer. J. Pathol., 223, 102-115.
7. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
8. Chen, J.F. et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet., 38, 228-233.
9. Chen, Y. et al. (2013) miR-200b inhibits TGF-ß1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis., 4, e541.
10. He, L. et al. (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet., 5, 522-531.
11. He, L. et al. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
12. Slaby, O. et al. (2009) MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol. Cancer, 8, 102.
13. Schetter, A.J. et al. (2011) Alterations of microRNAs contribute to colon carcinogenesis. Semin. Oncol., 38, 734-742.
14. Bhatti, I. et al. (2009) Small RNA: a large contributor to carcinogenesis? J. Gastrointest. Surg., 13, 1379-1388.
15. Ma, L. et al. (2007) Tumour invasion and metastasis initiated by micro-RNA-10b in breast cancer. Nature, 449, 682-688.
16. Song, B. et al. (2010) MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J. Exp. Clin. Cancer Res., 29, 29.
17. Korpal, M. et al. (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem., 283, 14910-14914.
18. Tavazoie, S.F. et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 451, 147-152.
19. Zhang, Y. et al. (2012) microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer. Oncol. Rep., 27, 685-694.
20. Kulda, V. et al. (2010) Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet. Cytogenet., 200, 154-160.
21. He, X. et al. (2012) MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol. Med., 18, 1491-1498.
22. Tazawa, H. et al. (2007) Tumor-suppressive miR-34a induces senescencelike growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA, 104, 15472-15477.
23. Michael, M.Z. et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
24. Link, A. et al. (2010) Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol. Biomarkers Prev., 19, 1766-1774.
25. Schepeler, T. et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res., 68, 6416-6424.
26. Schetter, A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
27. Sepramaniam, S. et al. (2010) MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J. Biol. Chem., 285, 29223-29230.
28. Yao, J. et al. (2012) GNAI1 suppresses tumor cell migration and invasion and is post-transcriptionally regulated by mir-320a/c/d in hepatocellular carcinoma. Cancer Biol. Med., 9, 234-241.
29. Hsieh, I.S. et al. (2013) MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis, 34, 530-538.
30. Bambang, I.F. et al. (2009) Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells. Lab. Invest., 89, 1229-1242.
31. Polyak, K. et al. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer, 9, 265-273.
32. Yang, J. et al. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 14, 818-829.
33. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454.
34. Leve, F. et al. (2012) Rho GTPase signaling in the development of colorectal cancer. J. Cell. Biochem., 113, 2549-2559.
35. Michiels, F. et al. (1995) A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature, 375, 338-340.
36. Zheng, Y. et al. (2012) Novel phosphatidylinositol 3-kinase inhibitor NVPBKM120 induces apoptosis in myeloma cells and shows synergistic antimyeloma activity with dexamethasone. J. Mol. Med. (Berl)., 90, 695-706.
37. Markowitz, S.D. et al. (2009) Molecular origins of cancer: Molecular basis of colorectal cancer. N. Engl. J. Med., 361, 2449-2460.
38. Hofsli, E. et al. (2013) Identification of serum microRNA profiles in colon cancer. Br. J. Cancer, 108, 1712-1719.
39. Liu, L. et al. (2013) The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression. PLoS One, 8, e55532.
40. Cheng, Z. et al. (2013) MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1. J. Clin. Immunol., 33, 567-576.
41. Feng, B. et al. (2012) miR-320 Regulates Glucose-Induced Gene Expression in Diabetes. ISRN Endocrinol., 2012, 549875.
42. Macartney-Coxson, D.P. et al. (2008) Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: candidate genes examined at the DNA, mRNA and protein level. BMC Cancer, 8, 187.
43. Knösel, T. et al. (2004) Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer. Neoplasia, 6, 23-28.
44. Thiery, J.P. et al. (2009) Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871-890.
45. Bracken, C.P. et al. (2009) The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cell. Mol. Life Sci., 66, 1682-1699.
46. Cano, A. et al. (2008) Non-coding RNAs take centre stage in epithelial-tomesenchymal transition. Trends Cell Biol., 18, 357-359.
47. Bracken, C.P. et al. (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res., 68, 7846-7854.
48. Burk, U. et al. (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep., 9, 582-589.
49. Etienne-Manneville, S. et al. (2002) Rho GTPases in cell biology. Nature, 420, 629-635.
50. Morimura, S. et al. (2011) Rac1 and stathmin but not EB1 are required for invasion of breast cancer cells in response to IGF-I. Int. J. Cell Biol., 2011, 615912.
51. Kamai, T. et al. (2010) Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer. BMC Cancer, 10, 164.
52. Ma, J. et al. (2013) Role of activated rac1/cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. PLoS One, 8, e66275.
53. de Toledo, M. et al. (2012) Cooperative anti-invasive effect of Cdc42/Rac1 activation and ROCK inhibition in SW620 colorectal cancer cells with elevated blebbing activity. PLoS One, 7, e48344.